We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Anesthesiology

Electroacupuncture Significantly Shortens Postoperative Ileus After Laparoscopic Gastrectomy for Gastric Cancer: Insights from a Multicenter Randomized Trial

MedXY Editorial Team•Oct 5, 2025•Anesthesiology
electroacupunctureGastric Cancerlaparoscopic gastrectomypostoperative ileus

Highlight

Electroacupuncture (EA) significantly reduces the time to first flatus and first defecation after laparoscopic gastrectomy for gastric cancer compared with sham EA and standard care. EA also lowers the incidence of prolonged postoperative ileus (POI) with no serious adverse events reported.

Study Background and Disease Burden

Postoperative ileus (POI) — a temporary impairment of bowel motility — is a common and challenging complication following laparoscopic gastrectomy for gastric cancer. It prolongs hospital stay, increases healthcare costs, and delays the initiation of oral nutrition, adversely impacting recovery and quality of life. Despite enhanced recovery after surgery (ERAS) protocols, effective interventions to shorten POI remain limited. Electroacupuncture (EA), an integrative therapy stimulating defined acupuncture points with electrical current, has shown promise in gastrointestinal motility modulation, but robust evidence in large clinical trials, especially for gastric cancer surgery, has been scarce.

Study Design

This was a rigorous, multicenter, randomized controlled trial conducted at seven hospitals across China. Between October 27, 2021, and December 21, 2023, 585 adult patients scheduled for laparoscopic gastrectomy for gastric cancer were enrolled. All participants received standard perioperative care, including ERAS elements.

Patients were randomized into three groups: four sessions of electroacupuncture (EA), four sessions of sham electroacupuncture (SA), or standard care alone without acupuncture. The primary efficacy endpoint was time to first flatus, a clinically relevant indicator of gastrointestinal recovery. Secondary endpoints included time to first defecation, dietary tolerance, quality of life measures, postoperative mobilization, and length of hospital stay.

Key Findings

Of 585 enrolled, 578 participants completed the full analysis set. The EA group showed a significant reduction in time to first flatus compared to SA and standard care groups. Specifically, EA reduced time to first flatus by about 13 hours relative to SA (95% CI, -19.17 to -6.75; P < .001) and by approximately 24.5 hours relative to standard care (95% CI, -30.61 to -18.30; P < .001).

Similarly, time to first defecation was reduced by 15.4 hours against SA (95% CI, -27.73 to -3.09; P = .007) and 24.7 hours versus standard care (95% CI, -36.76 to -12.55; P < .001) with EA. Beyond raw times, the incidence of prolonged POI was significantly lower in the EA arm — with risk difference reductions of 0.41 compared with SA and 0.56 versus standard care (both P < .001).

No severe adverse events related to EA or sham interventions were reported, indicating good safety and tolerability.

Expert Commentary

This trial provides strong high-quality evidence for clinicians and surgical teams aiming to reduce postoperative ileus following gastric cancer surgery. The sizeable sample, multicenter design, and inclusion of sham controls enhance the reliability and generalizability of these findings. Acupuncture’s role in modulating autonomic nervous system activity and promoting gastrointestinal motility may underlie the observed benefits.

However, further mechanistic studies could clarify specific neural or humoral pathways involved. Also, as the study population was exclusively Chinese patients, extrapolation to diverse ethnic groups requires careful validation. Attention to training and standardization of acupuncture procedure is critical to reproducibility.

Conclusion

Electroacupuncture is an effective adjunctive therapy that shortens postoperative ileus duration and accelerates gastrointestinal recovery in patients undergoing laparoscopic gastrectomy for gastric cancer. Its integration into perioperative care can enhance recovery without incurring serious adverse events, addressing a significant unmet clinical need. Future guidelines may consider recommending EA as part of multimodal ERAS programs tailored for gastric cancer surgery.

References

Pei L, Wang G, Yang S, Zhou S, Xu T, Zhou J, Zhang W, Lu K, Hu L, Wang Y, Wang K, You D, Wu Y, Li L, Guo J, Sun J. Electroacupuncture Reduces Duration of Postoperative Ileus After Laparoscopic Gastrectomy for Gastric Cancer: A Multicenter Randomized Trial. Gastroenterology. 2025 Jul;169(1):73-84. doi: 10.1053/j.gastro.2025.02.006. Epub 2025 Feb 18. PMID: 39978558.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Clinical Outcomes and Prognostic Factors in Lung Metastases Following Gastrectomy for Gastric CancerThis review summarizes the clinical characteristics, disease course, and survival outcomes of lung metastases after gastrectomy in gastric cancer patients, highlighting prognostic factors and the role of pulmonary metastasectomy.Sep 7, 2026Unveiling the Molecular Evolution from Primary Gastric Cancer to Peritoneal Metastases: Implications for Targeted Surgical OncologyThis study elucidates transcriptomic differences between primary gastric cancers and peritoneal metastases, revealing distinct tumor microenvironments and molecular pathways, highlighting potential targets for improved diagnosis and therapySep 5, 2026Genomic Profiling of Primary Gastric Tumors Predicts Recurrence Patterns and Survival OutcomesGenomic alterations in primary gastric tumors, including KRAS and PIK3CA mutations, correlate with recurrence risk and metastatic patterns, informing personalized postoperative surveillance and treatment strategies.Aug 9, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing &amp; care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Targeting SOX9-Driven SPEM Plasticity: A New Therapeutic Avenue to Prevent Gastric Cancer Progression
SOX9 is a pivotal regulator of SPEM cell plasticity driving gastric metaplasia and carcinogenesis. Therapeutically targeting SOX9 may prevent the progression of pre-cancerous lesions to gastric cancer by blocking metaplastic evolution.
Jul 16, 2026
Intraperitoneal and Intravenous Paclitaxel Plus S-1 for Gastric Cancer With Peritoneal Metastasis: Phase 3 TrialA phase 3 trial found that adding intraperitoneal paclitaxel to intravenous paclitaxel plus S-1 improved survival in gastric cancer with peritoneal metastasis without increasing severe toxicity.Jun 10, 2026
Effect of Electroacupuncture on Postherpetic Neuralgia: A Randomized Clinical TrialA randomized clinical trial found that electroacupuncture reduced pain more than sham treatment in postherpetic neuralgia, with benefits lasting at least one month and no major safety concerns.May 28, 2026